February 2015 FDA Recall Fentanyl Citrate by West-ward Pharmaceutical Corporation
D-0420-2015 - Failed Impurities/Degradation Specifications; 12 month stability testing.

This Class III drug recall was voluntarily initiated by West-ward Pharmaceutical Corporation on February 16, 2015 for the product Fentanyl Citrate. The FDA reported the reason for recall as failed impurities/degradation specifications; 12 month stability testing.. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0420-2015

Reason for Recall
Failed Impurities/Degradation Specifications; 12 month stability testing.
Initiated
02-16-2015
Reported
04-01-2015
Quantity
445,475 Vials

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
West-Ward Pharmaceutical Corporation
Fentanyl Citrate Inj., USP, CII, 250 mcg/5 mL (50 mcg/mL) (0.05 mg/mL) 25 x 5 mL Single Dose Vials, For Intravenous or Intramuscular Use, Preservative Free, Rx Only, Manufactured by: West-Ward Pharmaceuticals, Eatontown, NJ 07724, NDC 0641-6028-25.

Batch or Lot Expiration Information

Lot# : 113312, Exp 11/2015; 014315 Exp 01/2016